Deborah K Ayers

US Patent:

20130116150, May 9, 2013

Filed:

Jul 11, 2011

Appl. No.:

13/808751

Inventors:

Sheri Wilcox - Longmont CO, US
Deborah Ayers - Broomfield CO, US
Nebojsa Janjic - Boulder CO, US
Larry Gold - Boulder CO, US
Michael Riel-Mehan - Louisville CO, US
Thale Jarvis - Boulder CO, US

Assignee:

SOMALOGIC, INC. - Boulder CO

International Classification:

G01N 33/68
G06F 19/10
C12Q 1/68

US Classification:

506 9, 702 19

Abstract:

The present application includes biomarkers, methods, devices, reagents, systems, and kits for the detection and diagnosis of lung cancer. In one aspect, the application provides biomarkers that can be used alone or in various combinations to diagnose lung cancer or permit the differential diagnosis of pulmonary nodules as benign or malignant. In another aspect, methods are provided for diagnosing lung cancer in an individual, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 18, Table 20, or Table 21, wherein the individual is classified as having lung cancer, or the likelihood of the individual having lung cancer is determined, based on the at least one biomarker value.

US Patent:

20180275143, Sep 27, 2018

Filed:

May 30, 2018

Appl. No.:

15/993132

Inventors:

- Boulder CO, US
Deborah Ayers - Broomfield CO, US
Nebojsa Janjic - Boulder CO, US
Larry Gold - Boulder CO, US
Michael Riel-Mehan - San Marcos CA, US
Thale Jarvis - Boulder CO, US

International Classification:

G01N 33/68
G01N 33/574
C12Q 1/6886
G06F 19/10
G06F 19/18
G06F 19/20
G06F 19/24

Abstract:

The present application includes biomarkers, methods, devices, reagents, systems, and kits for the detection and diagnosis of lung cancer. In one aspect, the application provides biomarkers that can be used alone or in various combinations to diagnose lung cancer or permit the differential diagnosis of pulmonary nodules as benign or malignant. In another aspect, methods are provided for diagnosing lung cancer in an individual, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 18, Table 20, or Table 21, wherein the individual is classified as having lung cancer, or the likelihood of the individual having lung cancer is determined, based on the at least one biomarker value.